A detailed history of American Century Companies Inc transactions in Galapagos Nv stock. As of the latest transaction made, American Century Companies Inc holds 24,421 shares of GLPG stock, worth $643,981. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,421
Previous 23,711 2.99%
Holding current value
$643,981
Previous $587,000 19.76%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$24.2 - $30.67 $17,182 - $21,775
710 Added 2.99%
24,421 $703,000
Q1 2024

May 14, 2024

BUY
$32.2 - $42.44 $7,728 - $10,185
240 Added 1.02%
23,711 $763,000
Q4 2023

Feb 13, 2024

BUY
$31.87 - $40.71 $748,020 - $955,504
23,471 New
23,471 $954,000
Q3 2023

Nov 13, 2023

BUY
$34.17 - $42.98 $407,203 - $512,192
11,917 Added 116.72%
22,127 $764,000
Q2 2023

Aug 14, 2023

BUY
$37.4 - $44.52 $39,344 - $46,835
1,052 Added 11.49%
10,210 $415,000
Q1 2023

May 11, 2023

BUY
$36.5 - $48.0 $2,920 - $3,840
80 Added 0.88%
9,158 $353,000
Q4 2022

Feb 13, 2023

BUY
$37.44 - $46.51 $2,845 - $3,534
76 Added 0.84%
9,078 $402,000
Q3 2022

Nov 14, 2022

BUY
$42.27 - $57.6 $2,409 - $3,283
57 Added 0.64%
9,002 $384,000
Q2 2022

Aug 12, 2022

BUY
$52.3 - $71.59 $117,047 - $160,218
2,238 Added 33.37%
8,945 $499,000
Q1 2022

May 11, 2022

BUY
$51.32 - $68.5 $344,203 - $459,429
6,707 New
6,707 $416,000
Q4 2020

Feb 12, 2021

SELL
$96.85 - $148.25 $156,025 - $238,830
-1,611 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$122.47 - $213.56 $4,898 - $8,542
40 Added 2.55%
1,611 $229,000
Q2 2020

Aug 13, 2020

BUY
$185.52 - $231.25 $80,330 - $100,131
433 Added 38.05%
1,571 $310,000
Q1 2020

May 14, 2020

BUY
$143.0 - $274.03 $162,734 - $311,846
1,138 New
1,138 $223,000

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.74B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.